Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients

被引：116

作者：

Vellinga, M. M. ^{[1
]}

Castelijns, J. A. ^{[2
]}

Barkhof, F. ^{[2
]}

Uitdehaag, B. M. J. ^{[1
,3
]}

Polman, C. H. ^{[1
]}

机构：

[1] Vrije Univ Amsterdam, Ctr Med, Dept Neurol, NL-1081 HV Amsterdam, Netherlands

[2] Vrije Univ Amsterdam, Ctr Med, Dept Radiol, NL-1081 HV Amsterdam, Netherlands

[3] Vrije Univ Amsterdam, Ctr Med, MS Ctr, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands

来源：

NEUROLOGY | 2008年 / 70卷 / 13期

关键词：

D O I：

10.1212/01.wnl.0000265393.03231.e5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：1150 / 1151

页数：2

共 6 条

[1] Visual analysis of serial T2-weighted MRI in multiple sclerosis:: intra- and interobserver reproducibility [J].

Molyneux, PD ;

Miller, DH ;

Filippi, M ;

Yousry, TA ;

Radü, EW ;

Adèr, HJ ;

Barkhof, F .

NEURORADIOLOGY, 1999, 41 (12) :882-888

[2]

O'Connor PW, 2006, 22 C EUR COMM TREATM

[3] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis [J].

Polman, CH ;

O'Connor, PW ;

Havrdova, E ;

Hutchinson, M ;

Kappos, L ;

Miller, DH ;

Phillips, JT ;

Lublin, FD ;

Giovannoni, G ;

Wajgt, A ;

Toal, M ;

Lynn, F ;

Panzara, MA ;

Sandrock, AW .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) :899-910

[4] LOW-DOSE CYCLOSPORIN-A INDUCES RELAPSING REMITTING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE LEWIS RAT [J].

POLMAN, CH ;

MATTHAEI, I ;

DEGROOT, CJA ;

KOETSIER, JC ;

SMINIA, T ;

DIJKSTRA, CD .

JOURNAL OF NEUROIMMUNOLOGY, 1988, 17 (03) :209-216

[5] Natalizumab plus interferon beta-1a for relapsing multiple sclerosis [J].

Rudick, RA ;

Stuart, WH ;

Calabresi, PA ;

Confavreux, C ;

Galetta, SL ;

Radue, EW ;

Lublin, FD ;

Weinstock-Guttman, B ;

Wynn, DR ;

Lynn, F ;

Panzara, MA ;

Sandrock, AW ;

Fazekas, F ;

Enzinger, C ;

Seifert, T ;

Storch, M ;

Strasser-Fuchs, S ;

Berger, T ;

Dilitz, E ;

Egg, R ;

Deisenhammer, F ;

Decoo, D ;

Lampaert, J ;

Bartholome, E ;

Bier, J ;

Stenager, E ;

Rasmussen, M ;

Binzer, M ;

Shorsh, K ;

Christensen, M ;

Ravnborg, M ;

Sorensen, PS ;

Blinkenberg, M ;

Petersen, B ;

Hansen, HJ ;

Bech, E ;

Petersen, T ;

Kirkegaard, M ;

Eralinna, J ;

Ruutiainen, J ;

Soilu-Hänninen, M ;

Säkö, E ;

Laaksonen, M ;

Reunanen, M ;

Remes, A ;

Keskinarkaus, I ;

Moreau, T ;

Noblet, M ;

Rouaud, O ;

Couvreur, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) :911-923

[6] Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy [J].

Yousry, TA ;

Major, EO ;

Ryschkewitsch, C ;

Fahle, G ;

Fischer, S ;

Hou, J ;

Curfman, B ;

Miszkiel, K ;

Mueller-Lenke, N ;

Sanchez, E ;

Barkhof, F ;

Radue, EW ;

Jager, HR ;

Clifford, DB .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) :924-933

← 1 →